Off-label Use of Ceftazidime/Avibactam in Neonatal Intensive Care Unit: A Real-life Experience and Literature Review.

Argyro Ftergioti Melania Degli Antoni Angeliki Kontou Maria KourtiKalliopi PantzartziCharalampos Zarras Eleni Agakidou Kosmas Sarafidis Emmanuel Roilides Elias Iosifidis

Published in: The Pediatric infectious disease journal (2024)

Favorable clinical and microbiologic responses in neonatal intensive care unit patients treated with CZA off-label were observed without significant and unexpected adverse events in critically ill neonates.

Keyphrases

preterm infants
low birth weight
gram negative
case report
klebsiella pneumoniae
multidrug resistant
escherichia coli